FADS1 and Insulin resistance: These findings indicate that Sch B can regulate lipid metabolism and lipid droplet degradation by PPARγ, Plin2, Pck1, ACSL4 and Fads1 signaling pathway, while improving insulin resistance, thereby alleviating hepatic lipid accumulation caused by MAFLD.